Research Article

Network Pharmacology-Based Investigation of the Therapeutic Mechanisms of Action of Danning Tablets in Nonalcoholic Fatty Liver Disease

Table 3

The results of molecular docking simulation.

Protein (PDB ID)LigandFitness (Kcal/mol)Protein (PDB ID)LigandFitness (Kcal/mol)

IL6 (5FUC)NAG−82.47MAPK8 (2GMX)877−105.32
Quercetin−96.46Stigmasterol−103.52
Kaempferol−94.28β-Sitosterol−102.45
Supraene−93.65Supraene−98.66
Luteolin−86.82Luteolin−90.16
Stigmasterol−83.16Curcumenolactone C−88.64
Curcumenolactone C−78.64Quercetin−80.01
β-Sitosterol−78.38Kaempferol−78.28

VEGFA (6D3O)XCP−74.42CSP3 (3GJR)DZE−64.24
Quercetin−81.67Luteolin−109.76
Kaempferol−81.48Quercetin−101.75
Curcumenolactone C−65.03β-Sitosterol−93.91
Supraene−62.96Kaempferol−92.97
Luteolin−62.85Stigmasterol−90.54
Stigmasterol−53.81Supraene−85.62
β-Sitosterol−51.30Curcumenolactone C−82.71

MYC (5I4Z)GOLv42.74APP (3OVJ)ORA−89.52
Supraene−102.18Stigmasterol−82.77
β-Sitosterol−89.16β-Sitosterol−80.19
Stigmasterol−85.25Supraene−76.58
Luteolin−83.55Quercetin−69.45
Quercetin−78.06Luteolin−68.01
Kaempferol−73.66Kaempferol−66.05
Curcumenolactone C−71.46Curcumenolactone C−59.21

ALB (1E7A)PFL−69.57PPARG (2ATH)3EA−97.19
Stigmasterol−111.65Luteolin−99.33
Luteolin−107.49Stigmasterol−97.79
β-Sitosterol−100.86β-Sitosterol−95.81
Curcumenolactone C−93.57Supraene−93.44
Supraene−90.49Kaempferol−93.44
Quercetin−88.94Quercetin−91.09
Kaempferol−86.36Curcumenolactone C−83.09

RELA (3QXY)SAM−142.70RELA (3QXY)Kaempferol−107.02
Quercetin−113.07β-Sitosterol−95.78
Luteolin−110.22Stigmasterol−94.77
Supraene−107.85Curcumenolactone C−83.78

NAG, 877, XCP, DZE, GOL, ORA, PFL, 3EA, and SAM are the names of original ligands for corresponding targets in the PDB database.